VC-backed Edge Therapeutics goes public

Berkeley Heights, New Jersey-based Edge Therapeutics, a biotech company focused on developing therapies for neurological conditions, has debuted its IPO after pricing its over 7.3 million shares at $11 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “EDGE.” Leerink Partners and Credit Suisse are serving as the lead underwriters. Edge Therapeutics’ backers included Venrock, Sofinnova Ventures, Janus Capital Management LLC, New Leaf Venture Partners and BioMed Ventures.


Thoma Bravo to exit Sirius Computer Solutions

Kelso & Company has agreed to acquire a stake in Sirius Computer Solutions Inc, an information technology solutions provider. The sellers are Thoma Bravo and Sirius founder Harvey Najim. No financial terms were disclosed. The transaction is expected to be completed in the fourth quarter of this year. Credit Suisse is providing financial advice to Kelso on the deal.


Waterland Private Equity exits SENIOcare

Waterland Private Equity has sold its stake in Swiss nursing home operator SENIOcare to Swiss Prime Site AG. No financial terms were disclosed. Credit Suisse and Bär & Karrer provided advice to Waterland on the transaction.


Highstar Capital-backed Advanced Disposal files for IPO

Advanced Disposal, a provider of solid waste collection, transfer, recycling and disposal services, has filed for an IPO. The number of shares the stock will sell as well as its pricing terms have yet to be set. Deutsche Bank Securities, Credit Suisse and Barclays are serving as the lead underwriters. Advanced Disposal is backed by Highstar Capital.

Nomad to buy Findus Group’s European frozen food business

Nomad Foods has agreed to acquire Findus Group‘s European frozen food business for about 500 million pounds. The sellers, all of whom will receive 8.4 million shares of Nomad at the closing, include Highbridge Principal Strategies, Lion Capital LLP and Sankaty AdvisorsUBS Investment Bank and Credit Suisse provided financial advice to Nomad on the transaction.


PE HUB Second Opinion

In Second Opinion, nine are charged in an insider trading case tied to hackers, stocks tank after China devalues its currency and Columbia House files for bankruptcy and blames streaming for it.


Prodigy Finance fetches over $100 mln

International postgraduate student lender Prodigy Finance has raised over $100 million in funding, Balderton Capital, one of its backers, announced on its site. Other investors included Ed Wray, the co-founder of Betfair and Credit Suisse.


VC-backed Aimmune Therapeutics goes public

Brisbane, California-based Aimmune Therapeutics, a biopharmaceutical company focused on treating peanut allergies, has raised $160 million for its IPO after pricing its 10 million shares at $16 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “AIMT.” BofA Merrill Lynch, Credit Suisse and Piper Jaffray are serving as the lead underwriters. Aimmune’s backers include Longitude Capital, Foresite Capital and Aisling Capital.


Thoma Bravo buys iPipeline

Thoma Bravo has acquired Exton, Pennsylvania-based iPipeline, a tech provider of cloud-based software solutions for the life insurance sector. The sellers were NewSpring Capital, Technology Crossover Ventures and Volition Capital. No financial terms were disclosed. Golub Capital and Ares Capital Corp provided funding for the deal. Credit Suisse was the lead financial advisor to iPipeline on the transaction while Bank of America Merrill Lynch and William Blair served as co-advisors.


Blackstone to sell AVINTIV to Berry Plastics for about $2.45 bln

Berry Plastics Group Inc has agreed to acquire AVINTIV from The Blackstone Group LP for about $2.45 billion. The deal is expected to be completed by the end of the year. Credit Suisse and Barclays provided financial advice to Berry Plastics on the transaction while Citi and BofA Merrill Lynch did likewise for AVINTIV and Blackstone. Headquartered in Charlotte, North Carolina, AVINTIV is a specialty materials provider used in infection prevention, personal care, and high-performance solutions.


Veritas Capital to buy Alion

Veritas Capital said Thursday it has agreed to buy Alion Science and Technology Corp. Financial terms weren’t announced. Mclean, Virginia-based Alion provides engineering solutions and services that address issues relating to national defense, homeland security and other government areas. Credit Suisse and Wells Fargo advised Alion.


Nestlé Purina to buy Merrick Pet Care from Swander Pace

Swander Pace Capital is selling Merrick Pet Care to Nestlé Purina PetCare. Other sellers include company founder Garth Merrick, Monitor Clipper Partners and Highland Consumer Partners. No financial terms were disclosed. Credit Suisse provided financial advice to Swander Pace on the deal. Based in Amarillo, Texas, Merrick Pet Care is a natural and organic pet food company.

Immunocore racks up $320 mln

UK-based biotech company Immunocore Limited has closed $320 million in funding. The investors included Woodford Investment Management, Malin Corporation plc, Eli Lilly and Company and RTW Investments. Credit Suisse served as advisor to Immunocore on the transaction.


Delphix scores $75 mln

Fidelity Management and Research Company has led a $75 million funding round for Delphix, a Data as a Service provider. Other investors included Credit Suisse NEXT Investors LLC, The Kraft Group, Greylock Partners, Lightspeed Venture Partners and Icon Ventures.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget